Clinical Trials Unit

The Clinical Trials Unit (CTU) provides a central coordination function for new trials across The Royal Marsden.

The recently expanded team, based in the CTU at the Sutton site but also serving Chelsea, provides central support for designing, coordinating, analysing and publishing clinical trials and other well-designed studies. Investigator-initiated studies are welcomed from all clinical units, and investigators, with the support of the CTU, apply for external grant funding in order to support the additional activity.

The first trial to be run through the CTU will be the Patriot Trial, led by Professor Kevin Harrington, in collaboration with colleagues at University College London, Guy’s and St Thomas’ and Kings College London. This non-randomised, open-label, first-in-man Phase I study will examine safety and tolerability of AZD6738 as a single-agent and in combination with palliative radiation, and will provide a recommended dose for subsequent trials.

The expansion of the CTU is a significant step forward and exciting addition to the BRC’s research strategy, allowing us to fully maximise the potential for research excellence and ensure a more integrated system for research across all the units.

Researchers interested in running a trial through the CTU should contact Dr Rowena Sharpe, Assistant Director, BRC, or Sally Ellis, CTU Operations Manager.